Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Europe health tech report 2016


Published on

HealthTech is at the forefront of startups and scaleups, in the United States as well as in Europe. There is no single European healthcare system or market. Instead, high complexity and cultural diversity of healthcare systems makes it challenging to jump into multiple markets and thus to scaleup new companies. But if you take a close look, you’ll quickly notice that there is interesting stuff happening in Europe
With this report we want to provide a comprehensive review of investment in startups and high-growth HealthTech technology companies across 31 countries in Europe. Our aim is to provide data-driven guidance, insights, perspective and inspiration to stakeholders in the European scaleup ecosystem.

Published in: Health & Medicine
  • Login to see the comments

Europe health tech report 2016

  2. 2. 2 03 05 06 29 33 35 36 37 42 Foreword Highlights 2016 European HealthTech Scaleups Methodology About the authors About Sirris About dashplus Data sources Disclaimer TABLE OF CONTENTS
  3. 3. 3 2016 EUROPEAN HEALTHTECH REPORT FOREWORD PARTNERS HealthTech is at the forefront of startups and scaleups, in the United States as well as in Europe. There is no single European healthcare system or market. Instead, high complexity and cultural diversity of healthcare systems makes it challenging to jump into multiple markets and thus to scaleup new companies. But if you take a close look, you’ll quickly notice that there is interesting stuff happening in Europe With this report we want to provide a comprehensive review of investment in startups and high-growth HealthTech technology companies across 31 countries in Europe. Our aim is to provide data- driven guidance, insights, perspective and inspiration to stakeholders in the European scaleup ecosystem. We hope you find the 2016 edition of the report informative. Sincerely, Omar Mohout & Sofie Staelraeve
  4. 4. 4 This report is part of a series of funding reports, published both quarterly and yearly. Other reports complement the series, focusing on geographical markets and vertical industries such as the HealthTech report, written in collaboration with dashplus or the FinTech report in collaboration with Eggsplore. 2016 EUROPEAN HEALTHTECH REPORT ABOUT This report is a snapshot in time, aimed at analysing funding data, major trends within the industry and the regions. Only deals of at least $1M / € 750K are considered for this report. If you would like to provide your input for the report, signal an omission of data or have any other feedback, we would love to hear it. Just pop an email to and ABOUT THIS REPORT
  5. 5. HIGHLIGHTS 2016 5 • € 1.1B across 151 deals in 17 countries; • UK is leading both in funding and in number of deals; • The city with the highest number of deals is London, followed by Paris and Stockholm; • Bpifrance is the most active EU venture fund in Europe; • Hardware is the most popular business model and technology used by European HealthTech scaleups; • HealthTech is the second most funded industry in number of deals; • 4 European HealthTech companies went IPO raising € 102M; • 64% of European HealthTech scaleups are B2B oriented; • 4 HealthTech companies raised twice capital in the same year: Min Doktor, Coala Life, Brainshake & Sonitor Technologies. Remarkable, all 4 are from the Nordics. 2016 EUROPEAN HEALTHTECH REPORT HIGHLIGHTS
  7. 7. 7 € 294 € 174 € 121 € 110 € 91 € 57 € 50 € 40 € 37 € 33 € 21 € 20 € 18 € 14 € 7 € 7 € 1 UK Switzerland France Sweden Ireland Germany Belgium Serbia Spain Netherlands Norway Italy Poland Finland Denmark Austria Hungary 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL AMOUNT RAISED PER COUNTRY 2016* *In millions UK is leading, both in funding and in number of HealthTech deals in 2016. Switzerland is second best in terms of amount of capital raised. The gap between France/UK and Germany is significant. While tiny Sweden is performing in the same league as the biggest economy of Europe, almost hitting France. Other smaller countries such as Ireland and Belgium are doing well and are punching above their economic weight.
  8. 8. 8 33 27 18 11 11 8 7 6 6 6 6 4 4 1 1 1 1 UK France Sweden Belgium Germany Switzerland Netherlands Finland Ireland Spain Italy Norway Denmark Serbia Hungary Poland Austria 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL UK and France are leading. Sweden and Belgium are taking a very interesting 3rd and 4th position. No doubt Sweden is the rising star in Health, leaving Germany and Switzerland behind in amount of deals in 2016. Belgium is doing great. It seems like public agenda setting for digital transformation and creation of a startup ecosystem are paying off.. Germany has HealthTech growth potential. Compared to its other sectors, HealthTech investments are lagging behind. DEALS PER COUNTRY 2016
  9. 9. 9 € 63 € 137 € 80 € 120 € 89 € 82 € 106 € 32 € 66 € 56 € 93 € 170 Jan. Feb. Mar. Apr. May Jun. Jul. Aug. Sep. Oct. Nov. Dec. 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL CAPITAL RAISED 2016* *In millions European HealthTech scaleups together raise in average € 90 million per month. The highest peak In December is due to Oxford Nanopore Technologies raising € 119 million. The company tries to establish the concept of an “Internet of Living things”. 2 companies (HealthUnlocked, Infinity Health) used crowdfunding to raise growth capital.
  10. 10. 10 15 12 9 13 13 16 15 9 11 10 17 11 Jan. Feb. Mar. Apr. May Jun. Jul. Aug. Sep. Oct. Nov. Dec. 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL In average 13 HealthTech deals of at least € 750K are closed in Europe every month. NUMBER OF DEALS 2016
  11. 11. 11 47% 24% 14% 5% 3% 2% 1% 1% 1% 1% 1% Series A Seed Series B Series C IPO Crowdfunding Series G Grant Post IPO Equity Convertible Note Debt financing 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL Given the threshold of € 750K/$ 1M, it’s not surprising that the majority of deals are series A. Convertible notes are less popular in Europe and count for only 1%. DEAL TYPE 2016
  12. 12. 12 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL AVERAGE FOUNDING YEAR Finland Germany Switzerland 2010 Sweden Spain France UK Netherlands Ireland 2011 Denmark Italy 2012 Belgium 2013 To raise a series A in Europe, a company needs to be founded in 2011. It takes in average 5 (long!) years for HealthTech companies to raise substantial external financing. Austria 2014
  13. 13. 13 32 30 30 30 30 27 25 24 24 19 16 16 14 14 10 UK Ireland Norway Switzerland Spain Hungary Denmark France Germany Sweden Belgium Austria Finland Netherlands Italy 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL The number of employees is captured on the moment of fund raising and based on the press release, LinkedIn, Xing, Viadeo or the company’s website. On average, HealthTech scaleups have 26 employees. AVERAGE NUMBER OF EMPLOYEES PER COMPANY 2016
  14. 14. 1. London 2. Paris 3. Stockholm 4. Cambridge 5. Lausanne 6. Ghent 7. Barcelona 8. Oslo 9. Berlin 10. Dublin 1. Lausanne 2. Oxford 3. Stockholm 4. London 5. Paris 6. Cambridge 7. Blackrock 8. Belgrade 9. Dublin 10. Geneva 14 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL HEALTHTECH CITIES 2016 NUMBER OF DEALS AMOUNT RAISED London counts for 41% of all UK deals, Paris for 46%, Berlin for 34% and Stockholm for 56%. Barcelona, Ghent and Lausanne are the scaleup cities of their respective country instead of the capital cities. Note how the UK is the only country that has 3 cities (London, Cambridge and Oxford) in the list. 3 out of 5 Lausanne scale-ups raised more than € 10 million.
  15. 15. 15 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL We have split HealthTech into 4 sub categories: MedTech1. (typical being used by medical professionals and often requires connected hardware); CareTech2. (typical support the healthcare process such as booking platforms); HealthTech3. itself (typically being used by the patient directly) and; Lifescience4. (digital solution used by or for the life science industry). BREAKDOWN OF THE INDUSTRY CareTech 37% HealthTech 31% Lifescience 7% MedTech 25%
  16. 16. 64% 36% B2B B2C 78% 22% B2B B2C 16 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL B2B & B2C COMPARISON NUMBER OF DEALS AMOUNT RAISED European HealthTech is predominantly B2B. In general 64% of all scale-ups are B2B, that is some 6% points more than the overall scale-up ecosystem. B2C companies sign up for more deals, earlier after founding. But in general, they raise smaller amounts of capital. Top 10 of amount raised includes only 2 B2C companies: Frisq (Stockholm) and Clue (Berlin). Paris, London (UK), and Stockholm are the places to be for B2C HealthTech scaleups. Cambridge (UK), Switzerland and Ireland dominate B2B HealthTech deals. British Nanopore (B2B) and Swedish Frisk (B2C) raised the largest amount of money.
  17. 17. 17 100% 100% 88% 80% 80% 73% 69% 67% 60% 50% 50% 33% 33% 0% 0% 13% 20% 20% 27% 31% 33% 40% 50% 50% 67% 67% Ireland Netherlands Switzerland Finland Norway Belgium UK Italy Germany Denmark France Spain Sweden B2B B2C 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL B2B & B2C NUMBER OF DEALS PER COUNTRY Top 13 countries
  18. 18. 18 36% 17% 9% 7% 6% 4% 4% 4% 3% 3% 2% 2% Hardware Marketplace Wearable Data Analytics Artificial Intelligence SaaS App Internet of Things Video driven Robotics Virtual Reality 3D printing 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL Not surprisingly, hardware, traditionally very strong in the engineering cultures of European countries, is the leading business model for scaleups, counting for 34% of the total. France is leading in hardware and IoT while market places, robotics, video and apps is dominated by the UK. Sweden is the #1 spot for wearables and SaaS; Switzerland for 3D printing and video; Finland for data analytics, and Belgium for AI. TYPE OF BUSINESS MODELS/TECHNOLOGY 2016
  19. 19. 19 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL TOP 5 BIGGEST DEALS* € 119M € 89M € 39M€ 40M € 30M #01 #02 #03 #04 #05 *In amount raised
  20. 20. 20 23% 16% 12% 9% 9% 7% 7% 5% 5% 2% 2% 2% UK Belgium France Netherlands Italy Switzerland Germany Norway Sweden Denmark Hungary Ireland 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL 29% of European HealthTech scaleups are spin-offs or spin-outs from universities and knowledge institutes. Compared to only 8% of the scaleups across all industries, it indicates that the HealthTech ecosystem is strongly driven by IP that is generated in an academic environment. SPIN-OFFS BY COUNTRY 2016
  21. 21. 21 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL Note the extremely high performance of Belgium claiming more than half of the top positions, a testimony to the vibrant ecosystem going back to its long BioTech history. MOST ACTIVE SPIN-OFF INSTITUTES 2016 1. University of Cambridge (UK) 2. imec (Belgium) 3. University of Ghent (Belgium) 4. KULeuven (Belgium) 5. Inserm (France) 6. École Polytechnique Fédérale de Lausanne (Switzerland)
  22. 22. 22 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL 11% of the European HealthTech scaleups graduated from an acceleration program. That’s less than the 14% across all industries. Program alumni don’t necessary raise more money, but they are 1.5 years younger on average when they raise money. It might well be that they can start to scale earlier or have better access to investors thanks to acceleration programs. ACCELERATORS, BY NUMBER OF FUNDED SCALEUPS 2016 1. imec.istart (Belgium) 2. StartUp Health (Finland) 3. thinkubator (Denmark) 4. LeanSquare (Belgium) 5. Founders Factory (UK) 6. Accelerator London (UK) 7. Axel Springer Plug and Play (Germany) 8. StartupLab (Norway) 9. THINGS (Sweden) 10. Welcome City Lab (France) 11. M31 (Italy) 12. Project A Ventures (Germany) 13. SOSV (USA)
  23. 23. 23 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL Corporate Venture Capital is involved in 14% of all European deals and 18% of all capital raised. This is similar to other industries. The highest corporate investment was € 89M in Swiss MindMaze by Hinduja Group, an Indian conglomerate company that is headquartered in London. CORPORATE VENTURE CAPITAL INVESTORS 2016 ABB, Alex Springer, AXA, Bauer Media Group, Bonnier, Cnp Assurances, Fig, Furui Science, Henderson Land Development Company, Hinduja Group, Innocent drinks, Kaiser Permanente, Medtronic, Müller Medien Group, Nokia, NovioTech, ProSiebenSat.1, Puhua Jingxin Guzhou Health, Samsung, Seb, Swisscom, Telefónica, Tokai Optecs, TQ-Group, Unilever, Zürcher Kantonalbank
  24. 24. 24 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL The most active 2016 venture investor in Europe for HealthTech are the French and German government. Contrary to other industries, investors in HealthTech companies are European, not from the US. We believe that one of the reasons is that HealthTech is often subject to a number of regulation constraints and are heavily depending on national healthcare systems making it harder for VCs to assess the global potential. More than 350 funds and business angels made investments in HealthTech scaleups. MOST ACTIVE INVESTORS 1. Bpifrance (France) 2. High-Tech Gründerfonds (Germany) 3. Parkwalk Advisors (UK) 4. Bayern Kapital (Germany) 5. Capricorn Venture Partners (Belgium) 6. QBIC (Belgium) 7. Gilde Healthcare (Netherlands) 8. IQ Capital (UK) 9. Amadeus Capital Partners (UK) 10. Draper Esprit (UK)
  25. 25. 25 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL Europe saw four IPOs of HealthTech companies in 2016 totalling € 102M. 2 IPOs are from Swedish companies. Sweden also saw the youngest company going public, Cellink founded in 2016. Mainstay Medical, a public company from Ireland, raised € 30M in post- IPO equity from KCK. So did French Theraclion from Furui Science Co. IPO 2016 1. Cellink (Sweden, Nasdaq First North) 2. Frisq (Sweden, Nasdaq First North) 3. Creo Medical (UK, AIM) 4. Oneview Healthcare (Ireland, Australian Securities Exchange)
  26. 26. ADDITIONAL HIGHLIGHTS 2016 26 • Cellink, a Swedish 3D bioprinter company; is been established in January 2016 and went public 10 months later raising € 15M on Nasdaq First North; • Swedish Diasend, merged with Mountain View based Glooko into a unified company to create a leading diabetes management platform; • 4 HealthTech companies raised twice capital in the same year: Min Doktor, Coala Life, Brainshake & Sonitor Technologies. Remarkable, all 4 are from the Nordics; • Belgian based Indigo Diabetes raised capital from the highest number of investors: Thuja Capital, PMV, Sensinnovat, Parana Management Corp, Qbic, Fidimec, SOFI, Manuardeo and Capricorn Venture Partners; • Irish SiriusXT, a spin-off from University College Dublin, received a € 3M grant from the European Commission; • 8 HealthTech scaleups have more than 100 employees (Seven Bridges, Oxford Nanopore Technologies, Babylon Health, MonDocteur, T&J Healthcare, DocPlanner, Oneview Healthcare & SpineArt); • The oldest HealthTech company to receive growth capital is French Biolog- ID, founded in 1981; • 4 companies that are launched in 2016 received significant funding: Indigo Diabetes (Belgium), Eyeco Eyeco (Belgium), Cera (UK) & Cellink (Sweden); 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
  27. 27. HEALTHTECH SCALEUPS WITH REMARKABLE BUSINESS MODELS OR TECHNOLOGY 27 • French Nino Robotics: The personal transponder (wheelchair) of the new century; • Belgian Eyeco Eyeco: Introducing digital lenses with an uncompromising field of view, all the time; • French H4D: The Consult Stations are autonomous medical units replicating a medical doctor’s office; • Danish AthGene: subscription-based genetics platform; • Swedish Werlabs: a user picks up on the web shop what blood tests he or she wants to get done, pays the test online – and the next day one can head to take the test at both public and private clinics; • UK based MedShr and HealthUnlocked: both companies have a business model based on a community. For MedShr it’s for medical professionals and HealthUnlocked is for sufferers of Lupus. 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL
  28. 28. EUROPEAN VENTURE CAPITAL 2016 EUROPEAN HEALTHTECH REPORT EUROPEAN VENTURE CAPITAL Click on the above link to access the full dataset 28
  30. 30. 30 Scaleups, not startups, are generating added value, create jobs, expand international and create economic value for stakeholders and society. This group is attracting the lion share of (venture) capital, in some countries of up to 90% of all capital. In other words, we use the Pareto distribution rule to create an accurate view on the venturing landscape. Only deals of at least $1M / € 750K are considered. We encourage you to review the methodology to better understand the numbers presented in this report. We use a data-driven approach to track financing activity for European tech companies. Companies includes web, app, mobile, digital products and services, software, marketplace, connected hardware, data-driven and HardTech companies. Companies that have their HQ or launched in Europe are considered. LifeScience and BioTech (except software solutions targeting this industry), non digital CleanTech, eCommerce (Hallofresh, Zalando etc) and research institutes are excluded. 2016 EUROPEAN HEALTHTECH REPORT METHODOLOGY
  31. 31. 31 Deals with a non-disclosed value or lacking value indication are not counted. If an amount is described as a seven-figure number, the lowest possible value has been counted. Funding is registered based on announcement date. All currencies (USD, GBP, CHF, SEK etc) are converted to Euro using The number of employees is captured on the moment of fund raising and based on the press release, LinkedIn, Xing, Viadeo or the company’s website. The founding year and location is based on information in press releases, company website, Crunchbase, LinkedIn or Xing. If deal information is being detected or corrected after closing the month, quarter or year, it will be included in future reports. Funding of both private and public companies are considered. Debt financing, IPOs, media for equity, crowdfunding, Initial Coin Offering, private placements, post IPO equity, private equity, grants and convertible loans are included. 2016 EUROPEAN HEALTHTECH REPORT METHODOLOGY
  32. 32. 32 THE CATEGORIES ARE: HealthTech, CareTech, MedTech and Lifescience THE COUNTRIES ARE: Albania, Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland and UK. Data of Turkey and Israel is being used as a benchmark for Europe. 2016 EUROPEAN HEALTHTECH REPORT METHODOLOGY
  33. 33. 33 Omar Mohout is a former technology entrepreneur currently active as Growth Engineer at Sirris. Mohout is a widely published technology author, C-level advisor to high growth startups as well as Fortune 500 companies and Professor of Entrepreneurship at Antwerp Management School. He is author of 'Pricing Strategies for Startups', ‘The Belgian startup landscape’, ‘Crowdfunding in Belgium’ and the popular 'Startup Master Class series'. A contributing author to the ‘100 Days Digital Marketing Plan’ and ‘The Future of Business’ books. Mohout is a columnist; Co-chair of the Circle Of Growth, Organizer of the Growth Hacking Meetup, Co-founder of the #BeTech Community and Member of the Board of Directors at, Teamleader and Aproplan. He is also a mentor at Founder Institute, IdeaLabs, Startathlon, Virtuology Academy, Nexxworks and Belgium Ambassador at World Startup Report. Mohout is a keynote speaker and panellist on technology, entrepreneurship and innovation topics at leading conferences. 2016 EUROPEAN HEALTHTECH REPORT ABOUT THE AUTHOR OMAR MOHOUT
  34. 34. 34 Sofie is founder of dash_+, helping new health entrepreneurs and giving them the right fuel to shift to value-based health. Dash_+ focusses on partnerships, go to market and innovation strategy for new health companies and organisations. Sofie holds a Phd in Political Sciences. She specialised in public policy and innovation in periods of crisis and disruption. She worked in public, research and private environments. As a co-founder and director of the Voka Health Community in Belgium, she worked extensively with Belgian companies, health organisations, researchers and patient groups. Staelraeve is a member of the Belgian e-health platform, member of the board of Howest university college and member of the board of Syntra Vlaanderen. Sofie is author of several vision papers on the future of health. Together with Omar Mohout , she published ‘5 things you should know about Belgian HealthTech in 2017’. 2016 EUROPEAN HEALTHTECH REPORT ABOUT THE AUTHOR SOFIE STAELRAEVE
  35. 35. 35 Sirris, the collective centre of the Belgian technology industry, helps companies with the implementation of technological innovations, enabling them to strengthen their competitive position over the long-term. Sirris helps you make the best technological choice and rapidly turn your innovations into marketable products and services. The Sirris experts visit companies on site, offer technological advice, launch innovation paths, and provide guidance to reach the implementation phase. The aim is to find applicable solutions to the real challenges faced by technology entrepreneurs and startups. Sirris guides technology companies to a higher level of know-how and expertise in a wide range of domains. The in-house experts provide a broad range of technological and go-to-market knowledge. Where necessary, Sirris relies also on external knowledge partners, including specialized companies, universities, knowledge centres, and research institutions. For more information on how Sirris can help your company success, please visit 2016 EUROPEAN HEALTHTECH REPORT ABOUT SIRRIS
  36. 36. 36 2016 EUROPEAN HEALTHTECH REPORT ABOUT SIRRIS Dash_+ is your fast lane to new health entrepreneurship. We help health entrepreneurs all over Europe to define and implement their innovation strategy, to find and cooperate with new partners, and to accelerate their go to market. Our mission is to create integrated health companies: high value, innovative health companies and organizations, working together all along the value chain to create value based, sustainable healthcare. We work for (international) start ups, scale ups, big companies, care organisations, and public stakeholders. For more information on how dash_+ can help your company success, please visit
  37. 37. 37 2016 EUROPEAN HEALTHTECH REPORT SOURCES SPECIAL THANKS Serkan Ünsal, for covering Turkey and for the most detailed coverage of Europe WEBSITES & NEWSLETTERS 150sec,,,,, angellist, arcticstartup, avoltapartners, barcinno, beauhurst,,,, cbinsights,,, coindesk,,,, datafox,, dealroom, derbrutkasten,,,,,,,,, eu-startups,, finsmes,,,,,, GIMV,, noah conference,,,,,,,,,,,,,,, lightwaveonline,, loogic,, marketwatch, mattermark,,,,,,,,, pehub, pitchbook,, prnewswire,,,,,, siliconcanals,,,,,, startupjuncture,,,, startupticker,,,,,, techcitynews,,,,,,,, unquote, usine-digitale, vc-europe,,, webrazzi, websummit, widoobiz SOCIAL MEDIA Abyssinia, amaigre, atizo, AudingaJa, AudingaJar, austrianstartup, Barcinno, BeTech_, blpoland, boostturku, bot_innovation, Brainport_regio, breakit_se, BridgeBudapest, cdixon, chrysalisleap, chulu, ClujHub, CowboyGamedevBt, cphftw, csdeptucy, CyprusInno, davidcohen, Digital_Magics, dinaistwitting, DStartups, dublin_startups, dziennik, El_Startupero, Emerce, EndeavorGr, ericries, etohum, festivaluprise, frontiersci, goodnewsfinland, growthfunders, gruenderszene, health_xl, HelloPirates, hightechcampus, how_to_web, HUB13_Helsinki, hubvilnius, ICTSpring, ID_GC, ImpactHubBA, ImpactHubRO, impacthubzurich, ineshaeufler, InkubatorStart, inkubatorypl, Innovaspain, InnovAthens, InternetWeekLJ, istanbulstartup, iTXFROM, joonathan, JouveSud, Kbinkubators, KBinkubators, keskkyla,
  38. 38. 38 2016 EUROPEAN HEALTHTECH REPORT SOURCES SOCIAL MEDIA (CONT.) labsoflatvia, LAUNCHub, Leapfunder, LeumiTech, LisbonChallenge, LOFFICEbudapest, louishavri, LuceyFund, Lupacz, MadeinJLM, marketerslu, MassChallengeUK, masteringrowth, metavallon, miniforetak, MMKlaszter, MusicHackFest, NCBR_pl, nestholma, NeulogyVC, NewTrendBG, NoCamels, NorthstarVent, OsloInnoEmbassy, placeprint_mktg, ppmessengerpp, ProgramaMinerva, pt_startups, rp_teknoloji, Rubixlab, sama, saminnovatorene, sbcCopenhagen, SDigestCork, SeedstarsWorld, sektorfuenf, SICampNorway, SiliconLux, siliconvikings, SkatteFUNN, Smart_Ireland, SmartCity4Italy, socialbakers, sprout_nl, STAkrog, StarCubeCZ, startitup_sk, startup_italia, Startup_Kingdom, Startup_Podcast, StartUpBraga, startupbrett, StartupCampSK, startupestonia, startupgrind_LU, startupiceland, startupireland, startupjobsite, STARTUPLISBOA, StartupRVK, StartupsBe, startupturkey, startupvcnews, startupyard, StartUscc, stefanlundell, STHLMTech, summitdesignatx, swluxembourg, SwPrivateequity, Tech_Acad_Fin, tech_eu, TechBritannia, TechHubBuc, TechHubRiga, Technoport_, thecoulroom, thinkubator_dk, timwcap, tyinternety, VC_watcher, venturelab_ch, version2dk, Vienna_CM, VirginStartUp, webcampzg, webrazzi, whiteboardmag, WHMeanor, ZIPZg, KairosSocietyHU, SitraFund, ForumVirium, Tech_Acad_Fin, ReloadGreece, colabathens, bitspiration, NCBR_pl, blpoland, dziennik, CyberparkTGB, rp_teknoloji, sosyalmedyaco, IATurkije, czechcrunch, PerpetuumZg, helgosson, StartupGrindSWE, ZuoraEMEA, nyteknik, CampusLondon, growthfunders, VirginStartUp, MassChallengeUK, CognicityCW, INiTS_at, austrianstartup, IPNunes, SDigestCork, RyanAcademy, , LuceyFund, CrowdfundSpirit, kurtfinance, JouveSud, FuenteLatina, Silicon_wadi, BuildStuffLT, hightechcampus, HollandFinTech, Leapfunder, IMPACT_acc, ProgramaMinerva, playinglean, , Teknisk, NorskVenture, StartupLabNo, rp_teknoloji, sosyalmedyaco, sbcIstanbul, DLDConference, VC_watcher, startupradioDE, HTGF_, Lupacz, tyinternety, EconomyUp, SmartCity4Italy, Puglia_Startup, how_to_web, SeedstarsWorld, JeanneMazuret, ParkwalkAdvisor
  39. 39. 39 2016 EUROPEAN HEALTHTECH REPORT INVESTORS 20 North Street ,24Haymarket ,500 Startups ,5Lion Holdings ,7NXT ,A Plus Finance ,ABB Technology Ventures ,Ackermans & van Haaren ,Act One Ventures ,Adam Balon ,Adriaan Hart de Ruijter ,Advanced Manufacturing Supply Chain Initiative ,AIM ,Alec Behrens ,Alex Norström ,Alter Equity 3P ,Amadeus Capital Partners ,Anders Nyrén ,Angel CoFund ,Annie Vereecken ,Apposite Capital ,Aqui invest ,Aquitaine Limousin Poitou-Charentes ,Archangel Informal Investments ,Arnie Sriskandarajah ,Atlante Ventures ,Audacia ,Australian Securities Exchange ,AXA Strategic Ventures ,Axel Springer Plug and Play ,Axis ,Banexi Ventures ,Bauer Media Group ,Bayern Kapital ,BB Biotech Ventures ,BGF Ventures ,BioMedPartners ,Biover II ,Blue Ocean Ventures ,BNP Paribas Développement ,BNP Paribas Fortis ,Boehringer Ingelheim Venture Fund ,Bonnier ,Bonsai ,Bpifrance ,Brabant Development Agency ,Brigitte Mohn ,Broadview Ventures ,b-to-v Partners ,Cabiedes & Partners ,Caixa Capital Risc ,Cambridge Angels ,Cambridge Capital Group ,Cambridge Enterprise ,Cambridge Innovation Capital ,Canaan Partners ,Cap Horn Invest ,Capricorn Venture Partners ,CBC Holdings ,CEA ,CEA Investissement ,Christian W. Jansson ,Christophe Maire ,Cita Investissement ,Cnp Assurances ,Cor Group ,CPH ,Creandum ,Credo Ventures ,Crowdcube ,Daniel Ek ,David Buttress ,DBH Investment ,Demis Hassabis ,Downing Ventures ,Draper Esprit ,EBRD ,Efficient Capacity ,Egil Myklebust. ,EMESA ,ENERN Investments ,Enterprise Ireland ,EQT Ventures ,Esther Dyson ,European Commission ,Eventures ,F3F ,Faraday Venture Partners ,Fidimec ,Fig ,Filip Engelbert ,Finnvera ,Finovam ,FJ Labs ,Fondazione Cottino ,Forrestal Capital ,Forward Partners ,Founders Fund ,Fraunhofer Venture ,Furui Science Co ,Galia Gestion ,Gary Lin ,Gemma Frisius Fund ,Gilde Healthcare ,GIMV ,Giving Wings ,Global Founders Capital ,Global Sources ,Go Beyond Investing ,Greatbatch ,GT Healthcare ,Gustav Söderström ,Hampus Jakobsson ,Hanmi IT ,Harri Tilev ,Health Innovation Fund ,Health Innovations ,Henderson Land Development Company ,Herman Verrelst ,High-Tech Gründerfonds ,Hinduja Group ,Holland Venture ,Hoxton Ventures ,IDinvest Partners ,imec ,Imperial Innovations ,Index Ventures ,Inge K. Hansen ,Initiative Capital Romandie ,INKEF Capital ,Innogest ,Innovacom ,Innovation Capital ,Innovationsstarter Fonds ,Inserm Transfert Initiative ,Inven2 ,Inventure ,Inventures ,Invest4OncoDNA ,Invitalia Ventures ,IP Group ,IPF Partners ,IPG ,IQ Capital ,IRDInov ,Isabella Löwengrip ,Ixora Ventures ,Jaan Tallinn ,JamJar Investments ,Jan Schillebeeckx ,Johan Qviberg ,Joi Ito ,Jon Wright ,Jonas Nordlander ,Jonathan Milner ,K Fund ,Kainos ,Kaiser Permanente Ventures ,Kapor Capital ,Karl-Georg Altenburg ,KCK ,Kernel Capital ,Khaled Helioui ,Kima Ventures ,Kinled Holding ,Kinnevik ,Korys ,Kryssen Capital ,KULeuven ,Kurma Partners ,Kustaa Piha ,L1 Capital ,Lagardère Active ,Länsförsäkringar ,LanzaTech Ventures ,Lars Forslund ,Laura Iris Ferro ,Laurent Alexandre ,Laurent Leksell ,LF Invest ,LGT Global Invest ,Life Sciences Partners ,LocalGlobe ,London Business Angels ,London Co Investment Fund ,LSIF ,LSP ,Luc Vauterin ,M Capital Partners ,Magnus Kjøller ,Malakoff Médéric ,Manuardeo ,Marc Beuls ,Marcos Val ,Matthias Hilpert ,MedTech Innovation Partners ,Medtronic ,Mérieux Développement ,Metsola Ventures ,MeusInvest ,Mittelständische Beteiligungsgesellschaft Sachsen ,Monkfish Equity ,Mosaic Ventures ,Müller Medien ,Mustafa Suleyman ,Nasdaq First North ,New Enterprise Ventures ,NFT ventures ,Nick Robertson ,Noaber ,Nokia Growth Partners ,Nordea ,North West Fund ,NovioTech ,NSA Ventures ,Occident Group ,Octopus Ventures
  40. 40. 40 2016 EUROPEAN HEALTHTECH REPORT INVESTORS CONT. Oli Samwer ,Omnes Capital ,Ona Capital ,Oxford Capital ,Panakès Partners ,Par Equity ,Parana Management Corp ,Parkwalk Advisors ,Partech Ventures ,Passion Capital ,Perion Investment Fund ,Peter & Susanne Gjørup ,Peter Mellbye ,Peter Read ,PMV ,Polytech Ecosystem Ventures ,Project A Ventures ,Puhua Jingxin Guzhou Health Management ,QBIC ,Reaktor Ventures ,Richard Reed ,Robin Batchelor ,Sam Altman ,Sambrinvest ,Samsung Ventures ,Scottish Investment Bank ,Sean Duffy ,SEB Alliance ,Seedcamp ,Seedrs ,Sensinnovat ,Sergio Dompé ,Seventure Partners ,SevenVentures ,Si14 ,Siparex Proximité Innovation ,Slack Fund ,Social Capital ,SOFI ,Sofia Levander ,Sofimac ,Sofinim ,Sophia Bendz ,SOSV ,SparkLabs Global Ventures ,SRIW ,STMicroelectronics ,Sunstone Capital ,Svein Aaser ,Sven Arild Andersen ,Swarraton Partners ,Swiss Re ,Swisscom ,Target Global ,TechNano Fund ,Technology Venture Partners ,Tekes ,Telefónica Q-Growth ,The Chernin Group ,The Vandel Group ,Thomas Zeltner ,Thorleif Enger ,Thuja Capital ,Tim Jackson ,TJP Consulting ,Tom Singh ,Topfonds Gelderland ,Torsten Osthus ,TQ-Group ,Udo Müller ,Unilever Ventures ,Union Square Ventures ,University of Bristol Enterprise Fund ,University of Cambridge Enterprise ,Van Herk Ventures ,VentureFounders ,Vinsovier ,Vitamina K ,W3 ,Wellington Partners ,White Cloud Capital ,Woodford Investment Management ,Wren Capital ,Xavier Niel ,Xerys Gestion ,Yogen Dalal ,Ysios Capital ,ZKB
  41. 41. 41 2016 EUROPEAN HEALTHTECH REPORT SCALEUPS Abingdon Health, Acarix, Actronika, Aifloo, Alantaya, Aleva Neurotherapeutics, Arthro Therapeutics, AthGene, Ava Science, Babylon Health, Berlin Heals Holding, Big Health, BioBeats, Biolog-ID, Biomodex, Biovotion, Blackford Analysis, Bloom Technologies, Blow, Bluebee, Brainshake, Bucmi, Cambridge Medical Robotics, CarThera, Cellink, Cera, Cirdan, ClinicPoint, Clue, Coala Life, Creo Medical, Cunesoft, Cytomate Technologies, Devicare, D-Eye, Diasend, DocPlanner, Doctify, Doctor Anytime, Echo, Echolight, Emperra, Enxray, EveryLIFE Technologies, Eyeco Eyeco, Famly, FineHeart, Fluidic Analytics, Foundry Innovation & Research 1 (Fire1), Frisq, Genesis, Glamma, G-Therapeutics, H4D, HandInScan, Hapella, HealthUnlocked, Healx, HomeTouch, Horus Technology, i3 Membrane, Icometrix, Ignilife, Impulse Dynamics, Indigo Diabetes, Infinity Health, Interaction Healthcare, Irras, Joy, Junomedical, KB Medical, Keranova, Kiweno, Kolibree, KRY, Kyomed, Lifesum, LifeTime, Listen, Live Better With, Mainstay Medical, Massagio, MDLinking, Mdoloris, Medical Imaging Partnership, MedShr, MedUniverse, MesDocteurs, Micrima, microDimensions, Millidrop, Min Doktor, MindMaze, Mint Solutions, Molecubes, MonDocteur, Movendo Technology, Natural Cycles, NetMedi, Network Locum, Newronika, NightBalance, Nino Robotics, Noona, NovioSense, Numares, Nyxoah, OncoDNA, Oneview Healthcare, Ontoforce, Optics11, Otivio, Ōura, Owlstone Medical, Oxford Nanopore Technologies, Physidia, Popmyday, Promofarma, Psyomics, Push Doctor, Qaelum, Qualison, Quantum Imaging, ReActive Robotics, Rythm, Salupro, Saphetor, Scandinavian Real Heart, Sekoia, Seven Bridges, SiriusXT, snap40, Sonitor Technologies, Spectral Edge, Sphere Fluidics, SpineArt, STAT-Diagnostica, Surgivisio, T&J Healthcare, Teckro, The GP Service, Theraclion, Ugentec, UroMems, Visiomed Group, Werlabs, Zilico
  42. 42. 42 No dataset is complete and this report provides an indication of reality only. Comparing to reports of other providers on similar subjects is partly possible when taking into account the different methodologies. This report has been compiled for informational purpose only and should not be regarded as a solicitation to invest in any entity. This report relies on data and insights from a wide range of public and private sources and we can’t be hold responsible for the completeness and accuracy of the information provided. This report may freely be distributed, republished and posted as long as the content is not modified, decompiled or reference to the source is being removed. 2016 EUROPEAN HEALTHTECH REPORT DISCLAIMER
  43. 43. OmarMohout omohout @omohout Omar-Mohout FOLLOW OMAR ON LinkedIn Slideshare Twitter Facebook SofieStaelraeve Sofie Staelraeve @SofieStael FOLLOW SOFIE ON LinkedIn Slideshare Twitter